Tocqueville Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Tocqueville Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29,641	Closed	-$312K	–	538
2023 Q1	$312K	Hold	29,641	–	–	0.01%	452
2022 Q4	$367K	Buy	29,641 +1,110	+4%	+$12.6K	0.01%	475
2022 Q3	$296K	Hold	28,531	–	–	0.01%	515
2022 Q2	$329K	Hold	28,531	–	–	0.01%	557
2022 Q1	$359K	Hold	28,531	–	–	0.01%	578
2021 Q4	$333K	Hold	28,531	–	–	﹤0.01%	630
2021 Q3	$373K	Hold	28,531	–	–	0.01%	590
2021 Q2	$367K	Hold	28,531	–	–	0.01%	606
2021 Q1	$319K	Hold	28,531	–	–	﹤0.01%	631
2020 Q4	$325K	Hold	28,531	–	–	0.01%	608
2020 Q3	$257K	Hold	28,531	–	–	﹤0.01%	592
2020 Q2	$294K	Sell	28,531 -25,000	-47%	-$256K	0.01%	568
2020 Q1	$540K	Hold	53,531	–	–	0.01%	439
2019 Q4	$712K	Buy	53,531 +25,000	+88%	+$276K	0.01%	498
2019 Q3	$245K	Hold	28,531	–	–	﹤0.01%	688
2019 Q2	$312K	Sell	28,531 -5,535	-16%	-$62K	﹤0.01%	673
2019 Q1	$386K	Sell	34,066 -326	-0.9%	-$3.64K	0.01%	633
2018 Q4	$298K	Hold	34,392	–	–	﹤0.01%	628
2018 Q3	$532K	Hold	34,392	–	–	0.01%	607
2018 Q2	$551K	Sell	34,392 -965	-3%	-$14.3K	0.01%	586
2018 Q1	$457K	Hold	35,357	–	–	0.01%	627
2017 Q4	$444K	Hold	35,357	–	–	0.01%	639
2017 Q3	$467K	Hold	35,357	–	–	0.01%	631
2017 Q2	$559K	Hold	35,357	–	–	0.01%	578
2017 Q1	$505K	Hold	35,357	–	–	0.01%	587
2016 Q4	$453K	Sell	35,357 -23,880	-40%	-$302K	0.01%	618
2016 Q3	$788K	Hold	59,237	–	–	0.01%	539
2016 Q2	$649K	Hold	59,237	–	–	0.01%	581
2016 Q1	$543K	Hold	59,237	–	–	0.01%	613
2015 Q4	$575K	Sell	59,237 -1,054	-2%	-$10.2K	0.01%	634
2015 Q3	$526K	Hold	60,291	–	–	0.01%	690
2015 Q2	$609K	Hold	60,291	–	–	0.01%	670
2015 Q1	$808K	Hold	60,291	–	–	0.01%	622
2014 Q4	$774K	Hold	60,291	–	–	0.01%	624
2014 Q3	$654K	Hold	60,291	–	–	0.01%	569
2014 Q2	$774K	Hold	60,291	–	–	0.01%	629
2014 Q1	$622K	Sell	60,291 -1,194	-2%	-$13.4K	0.01%	533
2013 Q4	$598K	Hold	61,485	–	–	0.01%	545
2013 Q3	$610K	Hold	61,485	–	–	0.01%	601
2013 Q2	$511K	Buy	+61,485	New	+$745K	0.01%	629

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Tocqueville Asset Management's IRWD Position: Q2 2023 in Review

Tocqueville Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 29,641 shares — an estimated $312K sold.

Tocqueville Asset Management first reported a position in IRWD in Q2 2013 and held it in 40 quarters. The position peaked at $808K in Q1 2015. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

Tocqueville Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Tocqueville Asset Management sold 29,641 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $312K.
Tocqueville Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 40 quarters.
Tocqueville Asset Management's Ironwood Pharmaceuticals position peaked at $808K in Q1 2015.
252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Tocqueville Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.